Sinead Smith

Check out the latest updates on H. pylori infection in The Year in Helicobacter 2025! microbiotajournal.com/article/issues… @MicrobHealthDis @cocostigan @TjButler93 @christianmucLMU @JBornscheinUK @ehmsg

The better humans have gotten at making plastic, the more challenging it has been to unmake it—especially the pieces too small to see. Long after plastic bottles and bags break down, they keep fragmenting into particles so tiny, conventional filtration can’t touch them. They drift through treatment plants and into waterways unimpeded. There, they enter the food chain, and ultimately the body, where they have been found in human organs and are increasingly linked to various diseases such as cancer. Enter nanobots. In a new study, researchers show that tiny magnetic machines made of cagelike materials can tumble through water, sweeping up nanoplastics via the same electrostatic attraction that makes a balloon cling to your hair. Learn more: scim.ag/4ubx1ec @NewsfromScience

🧫H. pylori treatment helps prevent gastric cancer, but antibiotic resistance can reduce success. That’s why prevention strategies must consider resistance patterns & support adherence. TOGAS is building evidence for practical approaches to gastric cancer prevention across 🇪🇺.

Gastric cancer remains a major burden in Europe, but prevention is gaining momentum. EU initiatives advance H. pylori screening, data collection, and guidelines. Digestive Cancers Europe supports this progress through TOGAS. Read more: onlinelibrary.wiley.com/doi/10.1111/he…

🚀We are looking for 4 PIs to establish and lead independent research groups with 1.000.000 EUR internal grants at a new Kaunas-Kiel Microbiome & Precision Medicine Center 📢Please share this call and apply by 20th of May. nature.com/.../looking-fo…...

High Levels of Helicobacter pylori Antimicrobial Resistance in Ireland mdpi.com/3800502 #mdpimicroorganisms via @Micro_MDPI

🌍 Population-level gastric cancer prevention New article in The New England Journal of Medicine summarizes International Agency for Research on Cancer (IARC) Working Group recommendations on screen-and-treat programs for Helicobacter pylori🦠 With participation of @jp_gisbert, Principal Investigator of the Hp-EuReg and WorldHpReg 🔬 Eradication may reduce gastric cancer incidence by ~36% 🔗 nejm.org/doi/full/10.10… #Helicobacterpylori #GastricCancer #Prevention

🦠📊 New evidence on H. pylori management Large-scale data show evolving treatment strategies driven by antibiotic resistance and guideline updates. ⬇️ Decline of classic triple therapy ⬆️ Increased use of quadruple regimens for better eradication outcomes 🔗doi.org/10.1053/j.gast…

🦠 H. pylori treatment—what works best? 📊 Study of 26,000+ U.S. patients ✅ Quadruple therapies (concomitant & bismuth) ≈90% eradication 🔁 Bismuth = best salvage option ⚠️ Prior antibiotics ↓ success 🚫 Don’t repeat failed regimens 🔗[sciencedirect.com/science/articl…]

😯 A scientist once infected himself with H. pylori to prove it caused ulcers, and he was right. His bold step revolutionised treatment and linked the bacterium to gastric cancer. Today, testing is simple. TOGAS works to make H. pylori screening a reality across Europe.

H. pylori survives by neutralising stomach acid around it. This survival skill allows it to play a role in developing illnesses, even gastric cancer. That is why the TOGAS project is working to raise awareness about H. pylori and implement effective screening across the EU.

Treating the H. pylori stomach bacteria significantly lowers the risk of developing gastric cancer. 📉 A major new study confirms that screening and treating this infection is a powerful way to prevent cancer. 💊🦠 🔗gastrojournal.org/article/S0016-… @GastroJournalGJ

🗣️ This Gastric Cancer awareness month, let's talk about H. pylori! This bacteria affects more than half the world's population. H. pylori (Helicobacter pylori) is a risk factor for gastric cancer. Knowledge is your first line of defence!

📊 Why is the Gastric Cancer burden rising despite falling rates? While the individual risk of getting gastric cancer is decreasing globally, the absolute number of patients is rising due to population growth and ageing.

At#SVPD2025, 🇪🇸 Samuel J. Martínez-Domínguez shared key lessons from Hp-EuReg to improve H. pylori management: avoid OCA where ineffective, 7-day regimens, low PPI doses, repeated antibiotics, and unconfirmed eradication. 👏 @samu_martiinez @JoseMHuguet2

#GUTImage from the paper by Gong wet al entitled "CagA-dependent Hobit+ gastric tissue-resident memory T cells confer full protection from Helicobacter pylori reinfection" via bit.ly/47mm3K0 #HelicobacterPylori #MemoryTcells

Great new #GUTPodcast with Professor Christian Schulz from the Medical Department 2, LMU Munich, Munich, Germany on the paper "Helicobacter pylori antibiotic resistance: a global challenge in search of solutions" via ▶️ Apple: apple.co/3Wih9aD ▶️ Spotify: bit.ly/476PcJ5 ▶️ Web: bit.ly/3Wkh2LO Access the paper via bit.ly/3KcYOcj #HelicobacterPylori #AntibioticResistance @emadelomar

Multidrug-resistant Gram-negative bacterial infections - The Lancet (thelancet.com/journals/lance…)

🎙️ We are happy to introduce Dr. Katarzyna Neubauer, PhD, and Dr. Radosław Kempiński, MD, PhD, from Wrocław Medical University. Our consortium member, plays an important role in the TOGAS project. Watch the video to learn more about Wrocław Medical University's contributions.

#GUTImages from the paper by Liou et al on entitled "Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II" via bit.ly/46WArbS @sunnyheiwong @justntweet @emadelomar #HelicobacterPylori